Mar 29
|
Bristol Myers says KRAS drug succeeds in key trial
|
Mar 28
|
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
|
Mar 27
|
3 Biotech Stocks to Buy on the Dip: March 2024
|
Mar 27
|
7 Dow Stocks to Buy on the Dip: March 2024
|
Mar 26
|
Wall Street Set to Post Fifth Winning Month Amid Volatility
|
Mar 25
|
Buffett’s Backdoor Buys: 3 Stocks His Secret Portfolio Is Quietly Accumulating
|
Mar 24
|
16 Most Undervalued Large Cap Stocks To Buy According To Analysts
|
Mar 21
|
Hot Stocks: The 3 Best Opportunities for Investing in Biotech
|
Mar 20
|
Hot Stocks: The 3 Best Opportunities for Investing in the Dow
|
Mar 19
|
Amgen (AMGN) Ascends But Remains Behind Market: Some Facts to Note
|
Mar 18
|
Why Amgen (AMGN) Outpaced the Stock Market Today
|
Mar 14
|
13 Most Undervalued Blue Chip Stocks To Buy According To Analysts
|
Mar 12
|
Q4 2023 CytomX Therapeutics Inc Earnings Call
|
Mar 11
|
20 Highest Paying Countries for Biotechnology
|
Mar 11
|
15 Best NASDAQ Dividend Stocks To Buy
|
Mar 10
|
Obesity Drugs 2024: The Skinny on the Top 3 Weight-Loss Stocks
|
Mar 9
|
AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD 2024
|
Mar 8
|
Viking (VKTX) Stock Down on Novo Nordisk's Obesity Pill Data
|
Mar 7
|
Amgen (AMGN) Down 6.5% Since Last Earnings Report: Can It Rebound?
|
Mar 6
|
AMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDEND
|